{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:14:09Z","timestamp":1790118849244,"version":"4.0.1"},"reference-count":52,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol. Sin."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12250-021-00349-z","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T09:03:42Z","timestamp":1614848622000},"page":"721-729","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Artesunate and Dihydroartemisinin Inhibit Rabies Virus Replication"],"prefix":"10.1016","volume":"36","author":[{"given":"Jun","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiesen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongling","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwen","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3239-1072","authenticated-orcid":false,"given":"Shile","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2896-3629","authenticated-orcid":false,"given":"Xiaofeng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"key":"349_CR1","doi-asserted-by":"publisher","first-page":"4876","DOI":"10.1128\/JVI.02349-15","volume":"90","author":"W Aljabr","year":"2016","unstructured":"Aljabr W, Touzelet O, Pollakis G, Wu W, Munday DC, Hughes M, Hertz-Fowler C, Kenny J, Fearns R, Barr JN, Matthews DA, Hiscox JA (2016) Investigating the influence of ribavirin on human respiratory syncytial virus RNA synthesis by using a high-resolution transcriptome sequencing approach. J Virol 90:4876\u20134888","journal-title":"J Virol"},{"key":"349_CR2","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jviromet.2011.03.005","volume":"173","author":"S Auerochs","year":"2011","unstructured":"Auerochs S, Korn K, Marschall M (2011) A reporter system for Epstein\u2013Barr virus (EBV) lytic replication: anti-EBV activity of the broad anti-herpesviral drug artesunate. J Virol Methods 173:334\u2013339","journal-title":"J Virol Methods"},{"key":"349_CR3","doi-asserted-by":"publisher","first-page":"4686","DOI":"10.1016\/j.vaccine.2017.10.109","volume":"37","author":"AC Banyard","year":"2019","unstructured":"Banyard AC, Mansfield KL, Wu G, Selden D, Thorne L, Birch C, Koraka P, Osterhaus A, Fooks AR (2019) Re-evaluating the effect of Favipiravir treatment on rabies virus infection. Vaccine 37:4686\u20134693","journal-title":"Vaccine"},{"key":"349_CR4","doi-asserted-by":"publisher","first-page":"12019","DOI":"10.1002\/chem.202001803","volume":"26","author":"A Capci","year":"2020","unstructured":"Capci A, Lorion MM, Mai C, Hahn F, Hodek J, Wangen C, Weber J, Marschall M, Ackermann L, Tsogoeva SB (2020) (Iso)Quinoline-Artemisinin hybrids prepared through click chemistry: highly potent agents against viruses. Chemistry\u00a026:12019\u201312026","journal-title":"Chemistry"},{"key":"349_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3390\/microorganisms8010085","volume":"8","author":"S D'Alessandro","year":"2020","unstructured":"D\u2019Alessandro S, Scaccabarozzi D, Signorini L, Perego F, Ilboudo DP, Ferrante P, Delbue S (2020) The use of antimalarial drugs against viral infection. Microorganisms 8:85","journal-title":"Microorganisms"},{"key":"349_CR6","doi-asserted-by":"publisher","first-page":"535","DOI":"10.3851\/IMP3028","volume":"21","author":"E Drouot","year":"2016","unstructured":"Drouot E, Piret J, Boivin G (2016) Artesunate demonstrates in vitro synergism with several antiviral agents against human cytomegalovirus. Antivir Ther 21:535\u2013539","journal-title":"Antivir Ther"},{"key":"349_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.coviro.2018.12.009","volume":"35","author":"V Du Pont","year":"2019","unstructured":"Du Pont V, Plemper RK, Schnell MJ (2019) Status of antiviral therapeutics against rabies virus and related emerging lyssaviruses. Curr Opin Virol 35:1\u201313","journal-title":"Curr Opin Virol"},{"key":"349_CR8","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.intimp.2017.05.008","volume":"48","author":"Y Du","year":"2017","unstructured":"Du Y, Chen G, Zhang X, Yu C, Cao Y, Cui L (2017) Artesunate and erythropoietin synergistically improve the outcome of experimental cerebral malaria. Int Immunopharmacol 48:219\u2013230","journal-title":"Int Immunopharmacol"},{"key":"349_CR9","doi-asserted-by":"publisher","first-page":"4710","DOI":"10.1016\/j.vaccine.2017.12.028","volume":"37","author":"L Dufkova","year":"2019","unstructured":"Dufkova L, Sirmarova J, Salat J, Honig V, Palus M, Ruzek D, Fooks AR, Mansfield KL, Tordo N, Jochmans D, Neyts J, Martina B, Koraka P, Osterhaus ADME (2019) Mannitol treatment is not effective in therapy of rabies virus infection in mice. Vaccine 37:4710\u20134714","journal-title":"Vaccine"},{"key":"349_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.semcancer.2017.02.009","volume":"46","author":"T Efferth","year":"2017","unstructured":"Efferth T (2017) From ancient herb to modern drug: artemisia annua and artemisinin for cancer therapy. Semin Cancer Biol 46:65\u201383","journal-title":"Semin Cancer Biol"},{"key":"349_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00109-001-0300-8","volume":"80","author":"T Efferth","year":"2002","unstructured":"Efferth T, Marschall M, Wang X, Huong SM, Hauber I, Olbrich A, Kronschnabl M, Stamminger T, Huang ES (2002) Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant human cytomegaloviruses. J Mol Med (Berl) 80:233\u2013242","journal-title":"J Mol Med (Berl)"},{"key":"349_CR12","doi-asserted-by":"publisher","first-page":"7149","DOI":"10.1016\/j.vaccine.2009.09.034","volume":"27","author":"R Franka","year":"2009","unstructured":"Franka R, Wu X, Jackson FR, Velasco-Villa A, Palmer DP, Henderson H, Hayat W, Green DB, Blanton JD, Greenberg L, Rupprecht CE (2009) Rabies virus pathogenesis in relationship to intervention with inactivated and attenuated rabies vaccines. Vaccine 27:7149\u20137155","journal-title":"Vaccine"},{"issue":"Suppl","key":"349_CR13","doi-asserted-by":"publisher","first-page":"S20","DOI":"10.1016\/S0264-410X(96)00312-X","volume":"15","author":"ZF Fu","year":"1997","unstructured":"Fu ZF (1997) Rabies and rabies research: past, present and future. Vaccine 15(Suppl):S20\u2013S24","journal-title":"Vaccine"},{"key":"349_CR14","doi-asserted-by":"publisher","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","volume":"9","author":"K Hampson","year":"2015","unstructured":"Hampson K, Coudeville L, Lembo T, Sambo M, Kieffer A, Attlan M, Barrat J, Blanton JD, Briggs DJ, Cleaveland S, Costa P, Freuling CM, Hiby E, Knopf L, Leanes F, Meslin F, Metlin A, Miranda ME, Mueller T, Nel LH, Recuenco S, Rupprecht CE, Schumacher C, Taylor L, Natal Vigilato MA, Zinsstag J, Dushoff J (2015) Estimating the global burden of endemic canine rabies. PLoS Negl Trop Dis 9:e0003709","journal-title":"PLoS Negl Trop Dis"},{"key":"349_CR15","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1016\/S1473-3099(15)00079-1","volume":"15","author":"J Held","year":"2015","unstructured":"Held J, Supan C, Salazar CLO, Tinto H, Bonkian LN, Nahum A, Moulero B, Sie A, Coulibaly B, Sirima SB, Siribie M, Otsyula N, Otieno L, Abdallah AM, Kimutai R, Bouyou-Akotet M, Kombila M, Koiwai K, Cantalloube C, Din-Bell C, Djeriou E, Waitumbi J, Mordmueller B, Ter-Minassian D, Lell B, Kremsner PG (2015) Ferroquine and artesunate in African adults and children with Plasmodium falciparum malaria: a phase 2, multicentre, randomised, double-blind, dose-ranging, non-inferiority study. Lancet Infect Dis 15:1409\u20131419","journal-title":"Lancet Infect Dis"},{"key":"349_CR16","doi-asserted-by":"publisher","first-page":"18105","DOI":"10.1073\/pnas.0406927102","volume":"101","author":"A Kentsis","year":"2004","unstructured":"Kentsis A, Topisirovic I, Culjkovic B, Shao L, Borden KL (2004) Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proc Natl Acad Sci USA 101:18105\u201318110","journal-title":"Proc Natl Acad Sci USA"},{"key":"349_CR17","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/1348-0421.12192","volume":"58","author":"S Kihira","year":"2014","unstructured":"Kihira S, Uematsu J, Kawano M, Itoh A, Ookohchi A, Satoh S, Maeda Y, Sakai K, Yamamoto H, Tsurudome M, O\u2019Brien M, Komada H (2014) Ribavirin inhibits human parainfluenza virus type 2 replication in vitro. Microbiol Immunol 58:628\u2013635","journal-title":"Microbiol Immunol"},{"key":"349_CR18","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1186\/s12936-016-1532-y","volume":"15","author":"A Kume","year":"2016","unstructured":"Kume A, Dang TMA, Shichiri M, Ishida N, Suzuki H (2016) Probucol dramatically enhances dihydroartemisinin effect in murine malaria. Malar J 15:472","journal-title":"Malar J"},{"key":"349_CR19","doi-asserted-by":"publisher","first-page":"2267","DOI":"10.3892\/etm.2017.4232","volume":"13","author":"J Liu","year":"2017","unstructured":"Liu J, Hong X, Lin D, Luo X, Zhu M, Mo H (2017) Artesunate influences Th17\/Treg lymphocyte balance by modulating Treg apoptosis and Th17 proliferation in a murine model of rheumatoid arthritis. Exp Ther Med 13:2267\u20132273","journal-title":"Exp Ther Med"},{"key":"349_CR20","doi-asserted-by":"publisher","first-page":"104795","DOI":"10.1016\/j.phrs.2020.104795","volume":"159","author":"Y Long","year":"2020","unstructured":"Long Y, Yang Q, Xiang Y, Zhang Y, Wan J, Liu S, Li N, Peng W (2020) Nose to brain drug delivery\u2014a promising strategy for active components from herbal medicine for treating cerebral ischemia reperfusion. Pharmacol Res 159:104795","journal-title":"Pharmacol Res"},{"key":"349_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1038\/nmeth.1518","volume":"7","author":"J Louboutin","year":"2010","unstructured":"Louboutin J, Chekmasova AA, Marusich E, Chowdhury JR, Strayer DS (2010) Efficient CNS gene delivery by intravenous injection. Nat Methods 7:905\u2013909","journal-title":"Nat Methods"},{"key":"349_CR22","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.meegid.2013.03.046","volume":"17","author":"Y Luo","year":"2013","unstructured":"Luo Y, Zhang Y, Liu X, Yang Y, Yang X, Zheng Z, Deng X, Wu X, Guo X (2013) Characterization of a wild rabies virus isolate of porcine origin in China. Infect Genet Evol 17:147\u2013152","journal-title":"Infect Genet Evol"},{"key":"349_CR23","first-page":"e140586","volume":"10","author":"Z Luo","year":"2015","unstructured":"Luo Z, Tian D, Zhou M, Xiao W, Zhang Y, Li M, Sui B, Wang W, Guan H, Chen H, Fu ZF, Zhao L (2015) lambda-carrageenan P32 is a potent inhibitor of rabies virus infection. PLoS ONE 10:e140586","journal-title":"PLoS ONE"},{"key":"349_CR24","doi-asserted-by":"publisher","first-page":"4392","DOI":"10.1016\/j.vaccine.2016.07.020","volume":"34","author":"J Luo","year":"2016","unstructured":"Luo J, Shi H, Tan Y, Niu X, Long T, Zhao J, Tian Q, Wang Y, Chen H, Guo X (2016a) Two potential recombinant rabies vaccines expressing canine parvovirus virion protein 2 induce immunogenicity to canine parvovirus and rabies virus. Vaccine 34:4392\u20134398","journal-title":"Vaccine"},{"key":"349_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s11262-016-1313-2","volume":"52","author":"J Luo","year":"2016","unstructured":"Luo J, Zhao J, Tian Q, Mo W, Wang Y, Chen H, Guo X (2016b) A recombinant rabies virus carrying GFP between N and P affects viral transcription in vitro. Virus Genes 52:379\u2013387","journal-title":"Virus Genes"},{"key":"349_CR26","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.vaccine.2016.12.069","volume":"35","author":"J Luo","year":"2017","unstructured":"Luo J, Zhang B, Wu Y, Tian Q, Zhao J, Lyu Z, Zhang Q, Mei M, Luo Y, Guo X (2017) Expression of interleukin-6 by a recombinant rabies virus enhances its immunogenicity as a potential vaccine. Vaccine 35:938\u2013944","journal-title":"Vaccine"},{"key":"349_CR27","doi-asserted-by":"publisher","first-page":"7478","DOI":"10.1016\/j.vaccine.2019.09.077","volume":"37","author":"J Luo","year":"2019","unstructured":"Luo J, Zhang Y, He H, Liu Q, Huang S, Guo X (2019) Artesunate enhances the immune response of rabies vaccine as an adjuvant. Vaccine 37:7478\u20137481","journal-title":"Vaccine"},{"key":"349_CR28","doi-asserted-by":"publisher","first-page":"9650","DOI":"10.1096\/fj.201902577R","volume":"34","author":"J Luo","year":"2020","unstructured":"Luo J, Zhang B, Lyu Z, Wu Y, Zhang Y, Guo X (2020a) Single amino acid change at position 255 in rabies virus glycoprotein decreases viral pathogenicity. Faseb J 34:9650\u20139663","journal-title":"Faseb J"},{"key":"349_CR29","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3389\/fmicb.2020.00481","volume":"11","author":"J Luo","year":"2020","unstructured":"Luo J, Zhang B, Wu Y, Guo X (2020b) Amino acid mutation in position 349 of glycoprotein affect the pathogenicity of rabies virus. Front Microbiol 11:481","journal-title":"Front Microbiol"},{"key":"349_CR30","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1186\/1475-2875-13-501","volume":"13","author":"A Marijon","year":"2014","unstructured":"Marijon A, Bonnot G, Fourier A, Bringer C, Lavoignat A, Gagnieu MC, Bienvenu AL, Picot S (2014) Efficacy of intranasal administration of artesunate in experimental cerebral malaria. Malar J 13:501","journal-title":"Malar J"},{"key":"349_CR31","doi-asserted-by":"publisher","first-page":"4724","DOI":"10.1016\/j.vaccine.2018.05.066","volume":"37","author":"A Marosi","year":"2019","unstructured":"Marosi A, Dufkova L, Forro B, Felde O, Erdelyi K, Sirmarova J, Palus M, Honig V, Salat J, Tikos R, Gyuranecz M, Ruzek D, Martina B, Koraka P, Osterhaus A, Bakonyi T (2019) Combination therapy of rabies-infected mice with inhibitors of pro-inflammatory host response, antiviral compounds and human rabies immunoglobulin. Vaccine 37:4724\u20134735","journal-title":"Vaccine"},{"key":"349_CR32","doi-asserted-by":"publisher","first-page":"4736","DOI":"10.1016\/j.vaccine.2018.05.065","volume":"37","author":"BEE Martina","year":"2019","unstructured":"Martina BEE, Smreczak M, Orlowska A, Marzec A, Trebas P, Roose JM, Zmudzinski J, Gerhauser I, Wohlsein P, Baumgaertner W, Osterhaus ADME, Koraka P (2019) Combination drug treatment prolongs survival of experimentally infected mice with silver-haired bat rabies virus. Vaccine 37:4736\u20134742","journal-title":"Vaccine"},{"key":"349_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.jcv.2009.05.017","volume":"46","author":"J Milbradt","year":"2009","unstructured":"Milbradt J, Auerochs S, Korn K, Marschall M (2009) Sensitivity of human herpesvirus 6 and other human herpesviruses to the broad-spectrum antiinfective drug artesunate. J Clin Virol 46:24\u201328","journal-title":"J Clin Virol"},{"key":"349_CR34","doi-asserted-by":"publisher","first-page":"e134080","DOI":"10.1371\/journal.pone.0134080","volume":"10","author":"JM Musser","year":"2015","unstructured":"Musser JM, Heatley JJ, Koinis AV, Suchodolski PF, Guo J, Escandon P, Tizard IR (2015) Ribavirin inhibits parrot bornavirus 4 replication in cell culture. PLoS ONE 10:e134080","journal-title":"PLoS ONE"},{"key":"349_CR35","doi-asserted-by":"publisher","first-page":"e81783","DOI":"10.1371\/journal.pone.0081783","volume":"8","author":"S Obeid","year":"2013","unstructured":"Obeid S, Alen J, Nguyen VH, Pham VC, Meuleman P, Pannecouque C, Le TN, Neyts J, Dehaen W, Paeshuyse J (2013) Artemisinin analogues as potent inhibitors of in vitro hepatitis C virus replication. PLoS ONE 8:e81783","journal-title":"PLoS ONE"},{"key":"349_CR36","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1093\/carcin\/bgt277","volume":"35","author":"Y Odaka","year":"2014","unstructured":"Odaka Y, Xu B, Luo Y, Shen T, Shang C, Wu Y, Zhou H, Huang S (2014) Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells. Carcinogenesis 35:192\u2013200","journal-title":"Carcinogenesis"},{"key":"349_CR37","doi-asserted-by":"publisher","first-page":"85","DOI":"10.5501\/wjv.v5.i2.85","volume":"5","author":"MA Ramakrishnan","year":"2016","unstructured":"Ramakrishnan MA (2016) Determination of 50% endpoint titer using a simple formula. World J Virol 5:85\u201386","journal-title":"World J Virol"},{"key":"349_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.antiviral.2018.10.016","volume":"161","author":"S Rogee","year":"2019","unstructured":"Rogee S, Larrous F, Jochmans D, Ben-Khalifa Y, Neyts J, Bourhy H (2019) Pyrimethamine inhibits rabies virus replication in vitro. Antivir Res 161:1\u20139","journal-title":"Antivir Res"},{"key":"349_CR39","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.antiviral.2005.07.005","volume":"68","author":"MR Romero","year":"2005","unstructured":"Romero MR, Efferth T, Serrano MA, Castano B, Macias RI, Briz O, Marin JJ (2005) Effect of artemisinin\/artesunate as inhibitors of hepatitis B virus production in an \u201cin vitro\u201d replicative system. Antivir Res 68:75\u201383","journal-title":"Antivir Res"},{"key":"349_CR40","doi-asserted-by":"publisher","first-page":"7993","DOI":"10.1128\/JVI.00710-07","volume":"81","author":"A Roy","year":"2007","unstructured":"Roy A, Hooper DC (2007) Lethal silver-haired bat rabies virus infection can be prevented by opening the blood-brain barrier. J Virol 81:7993\u20137998","journal-title":"J Virol"},{"key":"349_CR41","doi-asserted-by":"crossref","unstructured":"Roy A, Phares TW, Koprowski H, Hooper DC (2007) Failure to open the blood-brain barrier and deliver immune effectors to central nervous system tissues leads to the lethal outcome of silver-haired bat rabies virus infection, 1110\u20131118","DOI":"10.1128\/JVI.01964-06"},{"key":"349_CR42","doi-asserted-by":"publisher","first-page":"265","DOI":"10.4103\/0974-8490.188874","volume":"8","author":"S Roy","year":"2016","unstructured":"Roy S, Mukherjee S, Pawar S, Chowdhary A (2016) Evaluation of In vitro Antiviral Activity of Datura metel Linn. Against rabies virus. Pharmacogn Res 8:265\u2013269","journal-title":"Pharmacogn Res"},{"key":"349_CR43","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.antiviral.2010.12.002","volume":"89","author":"N Schnepf","year":"2011","unstructured":"Schnepf N, Corvo J, Pors MJ, Mazeron MC (2011) Antiviral activity of ganciclovir and artesunate towards human cytomegalovirus in astrocytoma cells. Antivir Res 89:186\u2013188","journal-title":"Antivir Res"},{"key":"349_CR44","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1099\/jgv.0.001269","volume":"100","author":"SP Smith","year":"2019","unstructured":"Smith SP, Wu G, Fooks AR, Ma J, Banyard AC (2019) Trying to treat the untreatable: experimental approaches to clear rabies virus infection from the CNS. J Gen Virol 100:1171\u20131186","journal-title":"J Gen Virol"},{"key":"349_CR45","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3390\/v12020177","volume":"12","author":"TG Smith","year":"2020","unstructured":"Smith TG, Jackson FR, Morgan CN, Carson WC, Martin BE, Gallardo-Romero N, Ellison JA, Greenberg L, Hodge T, Squiquera L, Sulley J, Olson VA, Hutson CL (2020) Antiviral ranpirnase TMR-001 inhibits rabies virus release and cell-to-cell infection in vitro. Viruses 12:177","journal-title":"Viruses"},{"key":"349_CR46","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1016\/j.vaccine.2018.04.003","volume":"37","author":"M Smreczak","year":"2019","unstructured":"Smreczak M, Orlowska A, Marzec A, Trebas P, Kycko A, Reichert M, Koraka P, Osterhaus A, Zmudzinski JF (2019) The effect of combined drugs therapy on the course of clinical rabies infection in a murine model. Vaccine 37:4701\u20134709","journal-title":"Vaccine"},{"key":"349_CR47","first-page":"679090","volume":"2012","author":"MC Souza","year":"2012","unstructured":"Souza MC, Paixao FH, Ferraris FK, Ribeiro I, Henriques M (2012) Artesunate exerts a direct effect on endothelial cell activation and NF-kappaB translocation in a mechanism independent of plasmodium killing. Malar Res Treat 2012:679090","journal-title":"Malar Res Treat"},{"key":"349_CR48","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1186\/1475-2875-8-304","volume":"8","author":"B Tan","year":"2009","unstructured":"Tan B, Naik H, Jang I, Yu K, Kirsch LE, Shin C, Craft JC, Fleckenstein L (2009) Population pharmacokinetics of artesunate and dihydroartemisinin following single- and multiple-dosing of oral artesunate in healthy subjects. Malar J 8:304","journal-title":"Malar J"},{"key":"349_CR49","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13104-015-1000-8","volume":"8","author":"A van Tonder","year":"2015","unstructured":"van Tonder A, Joubert AM, Cromarty AD (2015) Limitations of the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay when compared to three commonly used cell enumeration assays. BMC Res Notes 8:47","journal-title":"BMC Res Notes"},{"key":"349_CR50","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.arcmed.2018.03.004","volume":"48","author":"L Wang","year":"2017","unstructured":"Wang L, Liu L, Wang J, Chen Y (2017) Inhibitory effect of artesunate on growth and apoptosis of gastric cancer cells. Arch Med Res 48:623\u2013630","journal-title":"Arch Med Res"},{"key":"349_CR51","doi-asserted-by":"publisher","first-page":"104810","DOI":"10.1016\/j.antiviral.2020.104810","volume":"179","author":"X Wang","year":"2020","unstructured":"Wang X, Zheng B, Ashraf U, Zhang H, Cao C, Li Q, Chen Z, Imran M, Chen H, Cao S, Ye J (2020) Artemisinin inhibits the replication of flaviviruses by promoting the type I interferon production. Antivir Res 179:104810","journal-title":"Antivir Res"},{"key":"349_CR52","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1093\/infdis\/jiv586","volume":"213","author":"K Yamada","year":"2016","unstructured":"Yamada K, Noguchi K, Komeno T, Furuta Y, Nishizono A (2016) Efficacy of favipiravir (T-705) in rabies postexposure prophylaxis. J Infect Dis 213:1253\u20131261","journal-title":"J Infect Dis"}],"container-title":["Virologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-021-00349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12250-021-00349-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12250-021-00349-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,4]],"date-time":"2022-01-04T06:39:56Z","timestamp":1641278396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12250-021-00349-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,4]]},"references-count":52,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["349"],"URL":"https:\/\/doi.org\/10.1007\/s12250-021-00349-z","relation":{},"ISSN":["1674-0769","1995-820X"],"issn-type":[{"value":"1674-0769","type":"print"},{"value":"1995-820X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,4]]},"assertion":[{"value":"5 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All animal experiments were approved by the Ethics Committee for Animal Experiments of the South China Agricultural University (ethics committee approval number: 2019014), and conducted in compliance with the Regulations for the Administration of Affairs Concerning Experimental Animals approved by the State Council of People\u2019s Republic of China.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Animal and Human Rights Statement"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}